Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases - Xu,L.; Yoneda,J.; Herrera,C.; Wood,J.; Killion,J.J.; Fidler,I.J. (Int J Oncol, 2000)